Targeting the Mechanism of Differentiation Arrest in a Novel Model of Acute Leukemia |
Massachusetts General Hospital / David Sykes |
Young Investigator Grants |
2011 |
Massachusetts |
Generation of a novel oncolytic virus for treatment of pediatric brain tumors.
|
The Ohio State University / Balveen Kaur, PhD |
Young Investigator Grants |
2007 |
Ohio |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies
|
Dana-Farber Cancer Institute / Ujwal Pyati |
Young Investigator Grants |
2009 |
Massachusetts |
Single Cell Signaling Profiles In High-Risk Pediatric Leukemia |
Stanford University / Kara Davis |
Young Investigator Grants |
2010 |
California |
GPC2 as an Oncogene and Immunotherapeutic Target in High-risk Neuroblastoma |
Children’s Hospital of Philadelphia / Kristopher Bosse, MD |
Young Investigator Grants |
2016 |
Pennsylvania |
Hematopoietic Stem And Progenitor Cells Sustain Inflammation And Promote Relapse In The AML Niche |
Children’s Hospital of Philadelphia / Ding-Wen (Roger) Chen, PhD |
Young Investigator Grants |
2021 |
Pennsylvania |
Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Regina Myers, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Genomic Alterations in ETV6 Predict Outcome in Pediatric AML |
Fred Hutchinson Cancer Research Center / Heather Helton, MD |
Young Investigator Grants |
2013 |
Washington |
Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia |
National Cancer Institute / Christopher Chien, PhD |
Young Investigator Grants |
2014 |
Maryland |